Time course of ethylcholine aziridinium ion (AF64A)-induced cholinotoxicity in vivo

The time course of the cholinotoxicity of ethylcholine aziridinium ion (AF64A) has been investigated. Rats were injected with AF64A (3 nmols/3 μ1/side, bilateral, i.e.v.) or with vehicle. One day to one year after treatment, the hippocampus, cortex and striatum were analyzed for the activity of chol...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neuropharmacology 1987-04, Vol.26 (4), p.361-365
Hauptverfasser: Leventer, S.M., Wulfert, E., Hanin, I.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 365
container_issue 4
container_start_page 361
container_title Neuropharmacology
container_volume 26
creator Leventer, S.M.
Wulfert, E.
Hanin, I.
description The time course of the cholinotoxicity of ethylcholine aziridinium ion (AF64A) has been investigated. Rats were injected with AF64A (3 nmols/3 μ1/side, bilateral, i.e.v.) or with vehicle. One day to one year after treatment, the hippocampus, cortex and striatum were analyzed for the activity of choline acetyltransferase (ChAT) and acetylcholinesterase (AChE) and high-affinity transport of choline (HAChT). In addition, the release of K +-stimulated acetylcholine (ACh) from superfused slices of hippocampus was determined. The first parameter affected was high affinity transport of choline. One day after treatment with AF64A, the high affinity transport of choline in the hippocampus was reduced by 23%. This reduction was maximal one week after treatment (−67%) and persisted for at least 6 months. The high affinity transport of choline in the striatum and cortex was not altered by treatment with AF64A. The activity of ChAT and AChE in the hippocampus was reduced by 2 days after treatment with AF64A. These deficits persisted for at least 6 months (AChE) to 1 year (ChAT). The activity of ChAT and AChE in the cortex and striatum was minimally affected up to 1 year after treatment with AF64A, at which time significant reductions were noted. The release of ACh was affected 3 days after treatment with AF64A, and remained attenuated 6 months later. These data indicate that the cholinergic deficit caused by in vivo treatment with AF64A was first apparent at the level of high affinity uptake of choline in the hippocampus HAChT. Subsequently, the activity of ChAT and AChE and release of ACh in the hippocampus were affected. In contrast to these early effects, cholinergic parameters in the cortex and striatum were affected much later (1 year after treatment).
doi_str_mv 10.1016/0028-3908(87)90189-4
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_77563385</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>0028390887901894</els_id><sourcerecordid>77563385</sourcerecordid><originalsourceid>FETCH-LOGICAL-c332t-baf1024105092f35e7f5b35583e02abdbef7db136e15f30bbf3aa315401f6e003</originalsourceid><addsrcrecordid>eNqFkEFv1DAQhS0EKtvCPwDJB4TaQ2Ac27H3UmlVUUCqxIFythxnrA5K4mInK5ZfT7a72iOc5vC-9zT6GHsj4IMA0XwEqG0l12Avrblag7DrSj1jK2GNrAw06jlbnZCX7LyUnwCgrLBn7Exqa7Q0K_b9ngbkIc25IE-R4_Sw68ND6mlE7v9Qpo5GmgdOaeSXm9tGba4qGrs5YMcPXJrSbwo07TiNfEvb9Iq9iL4v-Pp4L9iP20_3N1-qu2-fv95s7qogZT1VrY8CaiVAw7qOUqOJupVaW4lQ-7ZrMZquFbJBoaOEto3Seym0AhEbBJAX7P1h9zGnXzOWyQ1UAva9HzHNxRmjGymt_i8olBG2AbOA6gCGnErJGN1jpsHnnRPg9tLd3qjbG3XWuCfpTi21t8f9uR2wO5WOlpf83TH3Jfg-Zj8GKifMKCOFsQt2fcBwkbYlzK4EwnExTRnD5LpE__7jL0oDnMc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>14718607</pqid></control><display><type>article</type><title>Time course of ethylcholine aziridinium ion (AF64A)-induced cholinotoxicity in vivo</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Leventer, S.M. ; Wulfert, E. ; Hanin, I.</creator><creatorcontrib>Leventer, S.M. ; Wulfert, E. ; Hanin, I.</creatorcontrib><description>The time course of the cholinotoxicity of ethylcholine aziridinium ion (AF64A) has been investigated. Rats were injected with AF64A (3 nmols/3 μ1/side, bilateral, i.e.v.) or with vehicle. One day to one year after treatment, the hippocampus, cortex and striatum were analyzed for the activity of choline acetyltransferase (ChAT) and acetylcholinesterase (AChE) and high-affinity transport of choline (HAChT). In addition, the release of K +-stimulated acetylcholine (ACh) from superfused slices of hippocampus was determined. The first parameter affected was high affinity transport of choline. One day after treatment with AF64A, the high affinity transport of choline in the hippocampus was reduced by 23%. This reduction was maximal one week after treatment (−67%) and persisted for at least 6 months. The high affinity transport of choline in the striatum and cortex was not altered by treatment with AF64A. The activity of ChAT and AChE in the hippocampus was reduced by 2 days after treatment with AF64A. These deficits persisted for at least 6 months (AChE) to 1 year (ChAT). The activity of ChAT and AChE in the cortex and striatum was minimally affected up to 1 year after treatment with AF64A, at which time significant reductions were noted. The release of ACh was affected 3 days after treatment with AF64A, and remained attenuated 6 months later. These data indicate that the cholinergic deficit caused by in vivo treatment with AF64A was first apparent at the level of high affinity uptake of choline in the hippocampus HAChT. Subsequently, the activity of ChAT and AChE and release of ACh in the hippocampus were affected. In contrast to these early effects, cholinergic parameters in the cortex and striatum were affected much later (1 year after treatment).</description><identifier>ISSN: 0028-3908</identifier><identifier>EISSN: 1873-7064</identifier><identifier>DOI: 10.1016/0028-3908(87)90189-4</identifier><identifier>PMID: 3587537</identifier><identifier>CODEN: NEPHBW</identifier><language>eng</language><publisher>Oxford: Elsevier Ltd</publisher><subject>acetyl cholinesterase ; Acetylcholinesterase - metabolism ; ACh release (K + -stimulated acetylcholine release) ; AChE (acetylcholinesterase) ; AF64A (ethylcholine aziridinium ion) ; Animals ; Aziridines - pharmacology ; Azirines - pharmacology ; Biological and medical sciences ; brain ; Cerebral Cortex - drug effects ; Cerebral Cortex - metabolism ; ChAT (choline acetyltransferase) ; choline ; Choline - analogs &amp; derivatives ; Choline - metabolism ; Choline - pharmacology ; choline acetyltransferase ; Choline O-Acetyltransferase - metabolism ; Cholinergic Fibers - drug effects ; Cholinergic Fibers - metabolism ; Cholinergic system ; Corpus Striatum - drug effects ; Corpus Striatum - metabolism ; ethylcholine aziridinium ; HAChT (highaffinity choline transport) ; Hippocampus - drug effects ; Hippocampus - metabolism ; Injections, Intraventricular ; Male ; Medical sciences ; Neuropharmacology ; neurotoxicity ; Neurotransmitters. Neurotransmission. Receptors ; Pharmacology. Drug treatments ; Rats ; Rats, Inbred Strains ; Time Factors</subject><ispartof>Neuropharmacology, 1987-04, Vol.26 (4), p.361-365</ispartof><rights>1987</rights><rights>1988 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c332t-baf1024105092f35e7f5b35583e02abdbef7db136e15f30bbf3aa315401f6e003</citedby><cites>FETCH-LOGICAL-c332t-baf1024105092f35e7f5b35583e02abdbef7db136e15f30bbf3aa315401f6e003</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/0028-3908(87)90189-4$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,777,781,3537,27905,27906,45976</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=7473178$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/3587537$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Leventer, S.M.</creatorcontrib><creatorcontrib>Wulfert, E.</creatorcontrib><creatorcontrib>Hanin, I.</creatorcontrib><title>Time course of ethylcholine aziridinium ion (AF64A)-induced cholinotoxicity in vivo</title><title>Neuropharmacology</title><addtitle>Neuropharmacology</addtitle><description>The time course of the cholinotoxicity of ethylcholine aziridinium ion (AF64A) has been investigated. Rats were injected with AF64A (3 nmols/3 μ1/side, bilateral, i.e.v.) or with vehicle. One day to one year after treatment, the hippocampus, cortex and striatum were analyzed for the activity of choline acetyltransferase (ChAT) and acetylcholinesterase (AChE) and high-affinity transport of choline (HAChT). In addition, the release of K +-stimulated acetylcholine (ACh) from superfused slices of hippocampus was determined. The first parameter affected was high affinity transport of choline. One day after treatment with AF64A, the high affinity transport of choline in the hippocampus was reduced by 23%. This reduction was maximal one week after treatment (−67%) and persisted for at least 6 months. The high affinity transport of choline in the striatum and cortex was not altered by treatment with AF64A. The activity of ChAT and AChE in the hippocampus was reduced by 2 days after treatment with AF64A. These deficits persisted for at least 6 months (AChE) to 1 year (ChAT). The activity of ChAT and AChE in the cortex and striatum was minimally affected up to 1 year after treatment with AF64A, at which time significant reductions were noted. The release of ACh was affected 3 days after treatment with AF64A, and remained attenuated 6 months later. These data indicate that the cholinergic deficit caused by in vivo treatment with AF64A was first apparent at the level of high affinity uptake of choline in the hippocampus HAChT. Subsequently, the activity of ChAT and AChE and release of ACh in the hippocampus were affected. In contrast to these early effects, cholinergic parameters in the cortex and striatum were affected much later (1 year after treatment).</description><subject>acetyl cholinesterase</subject><subject>Acetylcholinesterase - metabolism</subject><subject>ACh release (K + -stimulated acetylcholine release)</subject><subject>AChE (acetylcholinesterase)</subject><subject>AF64A (ethylcholine aziridinium ion)</subject><subject>Animals</subject><subject>Aziridines - pharmacology</subject><subject>Azirines - pharmacology</subject><subject>Biological and medical sciences</subject><subject>brain</subject><subject>Cerebral Cortex - drug effects</subject><subject>Cerebral Cortex - metabolism</subject><subject>ChAT (choline acetyltransferase)</subject><subject>choline</subject><subject>Choline - analogs &amp; derivatives</subject><subject>Choline - metabolism</subject><subject>Choline - pharmacology</subject><subject>choline acetyltransferase</subject><subject>Choline O-Acetyltransferase - metabolism</subject><subject>Cholinergic Fibers - drug effects</subject><subject>Cholinergic Fibers - metabolism</subject><subject>Cholinergic system</subject><subject>Corpus Striatum - drug effects</subject><subject>Corpus Striatum - metabolism</subject><subject>ethylcholine aziridinium</subject><subject>HAChT (highaffinity choline transport)</subject><subject>Hippocampus - drug effects</subject><subject>Hippocampus - metabolism</subject><subject>Injections, Intraventricular</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Neuropharmacology</subject><subject>neurotoxicity</subject><subject>Neurotransmitters. Neurotransmission. Receptors</subject><subject>Pharmacology. Drug treatments</subject><subject>Rats</subject><subject>Rats, Inbred Strains</subject><subject>Time Factors</subject><issn>0028-3908</issn><issn>1873-7064</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1987</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkEFv1DAQhS0EKtvCPwDJB4TaQ2Ac27H3UmlVUUCqxIFythxnrA5K4mInK5ZfT7a72iOc5vC-9zT6GHsj4IMA0XwEqG0l12Avrblag7DrSj1jK2GNrAw06jlbnZCX7LyUnwCgrLBn7Exqa7Q0K_b9ngbkIc25IE-R4_Sw68ND6mlE7v9Qpo5GmgdOaeSXm9tGba4qGrs5YMcPXJrSbwo07TiNfEvb9Iq9iL4v-Pp4L9iP20_3N1-qu2-fv95s7qogZT1VrY8CaiVAw7qOUqOJupVaW4lQ-7ZrMZquFbJBoaOEto3Seym0AhEbBJAX7P1h9zGnXzOWyQ1UAva9HzHNxRmjGymt_i8olBG2AbOA6gCGnErJGN1jpsHnnRPg9tLd3qjbG3XWuCfpTi21t8f9uR2wO5WOlpf83TH3Jfg-Zj8GKifMKCOFsQt2fcBwkbYlzK4EwnExTRnD5LpE__7jL0oDnMc</recordid><startdate>198704</startdate><enddate>198704</enddate><creator>Leventer, S.M.</creator><creator>Wulfert, E.</creator><creator>Hanin, I.</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>8FD</scope><scope>FR3</scope><scope>M7Z</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>198704</creationdate><title>Time course of ethylcholine aziridinium ion (AF64A)-induced cholinotoxicity in vivo</title><author>Leventer, S.M. ; Wulfert, E. ; Hanin, I.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c332t-baf1024105092f35e7f5b35583e02abdbef7db136e15f30bbf3aa315401f6e003</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1987</creationdate><topic>acetyl cholinesterase</topic><topic>Acetylcholinesterase - metabolism</topic><topic>ACh release (K + -stimulated acetylcholine release)</topic><topic>AChE (acetylcholinesterase)</topic><topic>AF64A (ethylcholine aziridinium ion)</topic><topic>Animals</topic><topic>Aziridines - pharmacology</topic><topic>Azirines - pharmacology</topic><topic>Biological and medical sciences</topic><topic>brain</topic><topic>Cerebral Cortex - drug effects</topic><topic>Cerebral Cortex - metabolism</topic><topic>ChAT (choline acetyltransferase)</topic><topic>choline</topic><topic>Choline - analogs &amp; derivatives</topic><topic>Choline - metabolism</topic><topic>Choline - pharmacology</topic><topic>choline acetyltransferase</topic><topic>Choline O-Acetyltransferase - metabolism</topic><topic>Cholinergic Fibers - drug effects</topic><topic>Cholinergic Fibers - metabolism</topic><topic>Cholinergic system</topic><topic>Corpus Striatum - drug effects</topic><topic>Corpus Striatum - metabolism</topic><topic>ethylcholine aziridinium</topic><topic>HAChT (highaffinity choline transport)</topic><topic>Hippocampus - drug effects</topic><topic>Hippocampus - metabolism</topic><topic>Injections, Intraventricular</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Neuropharmacology</topic><topic>neurotoxicity</topic><topic>Neurotransmitters. Neurotransmission. Receptors</topic><topic>Pharmacology. Drug treatments</topic><topic>Rats</topic><topic>Rats, Inbred Strains</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Leventer, S.M.</creatorcontrib><creatorcontrib>Wulfert, E.</creatorcontrib><creatorcontrib>Hanin, I.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biochemistry Abstracts 1</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Neuropharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Leventer, S.M.</au><au>Wulfert, E.</au><au>Hanin, I.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Time course of ethylcholine aziridinium ion (AF64A)-induced cholinotoxicity in vivo</atitle><jtitle>Neuropharmacology</jtitle><addtitle>Neuropharmacology</addtitle><date>1987-04</date><risdate>1987</risdate><volume>26</volume><issue>4</issue><spage>361</spage><epage>365</epage><pages>361-365</pages><issn>0028-3908</issn><eissn>1873-7064</eissn><coden>NEPHBW</coden><abstract>The time course of the cholinotoxicity of ethylcholine aziridinium ion (AF64A) has been investigated. Rats were injected with AF64A (3 nmols/3 μ1/side, bilateral, i.e.v.) or with vehicle. One day to one year after treatment, the hippocampus, cortex and striatum were analyzed for the activity of choline acetyltransferase (ChAT) and acetylcholinesterase (AChE) and high-affinity transport of choline (HAChT). In addition, the release of K +-stimulated acetylcholine (ACh) from superfused slices of hippocampus was determined. The first parameter affected was high affinity transport of choline. One day after treatment with AF64A, the high affinity transport of choline in the hippocampus was reduced by 23%. This reduction was maximal one week after treatment (−67%) and persisted for at least 6 months. The high affinity transport of choline in the striatum and cortex was not altered by treatment with AF64A. The activity of ChAT and AChE in the hippocampus was reduced by 2 days after treatment with AF64A. These deficits persisted for at least 6 months (AChE) to 1 year (ChAT). The activity of ChAT and AChE in the cortex and striatum was minimally affected up to 1 year after treatment with AF64A, at which time significant reductions were noted. The release of ACh was affected 3 days after treatment with AF64A, and remained attenuated 6 months later. These data indicate that the cholinergic deficit caused by in vivo treatment with AF64A was first apparent at the level of high affinity uptake of choline in the hippocampus HAChT. Subsequently, the activity of ChAT and AChE and release of ACh in the hippocampus were affected. In contrast to these early effects, cholinergic parameters in the cortex and striatum were affected much later (1 year after treatment).</abstract><cop>Oxford</cop><pub>Elsevier Ltd</pub><pmid>3587537</pmid><doi>10.1016/0028-3908(87)90189-4</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0028-3908
ispartof Neuropharmacology, 1987-04, Vol.26 (4), p.361-365
issn 0028-3908
1873-7064
language eng
recordid cdi_proquest_miscellaneous_77563385
source MEDLINE; Elsevier ScienceDirect Journals
subjects acetyl cholinesterase
Acetylcholinesterase - metabolism
ACh release (K + -stimulated acetylcholine release)
AChE (acetylcholinesterase)
AF64A (ethylcholine aziridinium ion)
Animals
Aziridines - pharmacology
Azirines - pharmacology
Biological and medical sciences
brain
Cerebral Cortex - drug effects
Cerebral Cortex - metabolism
ChAT (choline acetyltransferase)
choline
Choline - analogs & derivatives
Choline - metabolism
Choline - pharmacology
choline acetyltransferase
Choline O-Acetyltransferase - metabolism
Cholinergic Fibers - drug effects
Cholinergic Fibers - metabolism
Cholinergic system
Corpus Striatum - drug effects
Corpus Striatum - metabolism
ethylcholine aziridinium
HAChT (highaffinity choline transport)
Hippocampus - drug effects
Hippocampus - metabolism
Injections, Intraventricular
Male
Medical sciences
Neuropharmacology
neurotoxicity
Neurotransmitters. Neurotransmission. Receptors
Pharmacology. Drug treatments
Rats
Rats, Inbred Strains
Time Factors
title Time course of ethylcholine aziridinium ion (AF64A)-induced cholinotoxicity in vivo
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-21T07%3A55%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Time%20course%20of%20ethylcholine%20aziridinium%20ion%20(AF64A)-induced%20cholinotoxicity%20in%20vivo&rft.jtitle=Neuropharmacology&rft.au=Leventer,%20S.M.&rft.date=1987-04&rft.volume=26&rft.issue=4&rft.spage=361&rft.epage=365&rft.pages=361-365&rft.issn=0028-3908&rft.eissn=1873-7064&rft.coden=NEPHBW&rft_id=info:doi/10.1016/0028-3908(87)90189-4&rft_dat=%3Cproquest_cross%3E77563385%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=14718607&rft_id=info:pmid/3587537&rft_els_id=0028390887901894&rfr_iscdi=true